Lipid Modification Database
Tag Content
LipidDB ID
LipidDB-9606-00256
Entry Name
UniProt Accession
Theoretical PI
8.2
Molecular Weight
131117.23
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
Nitric oxide synthase, inducible
Protein Synonyms/Alias
1.14.13.39; Hepatocyte NOS; HEP-NOS; Inducible NO synthase; Inducible NOS; iNOS; NOS type II; Peptidyl-cysteine S-nitrosylase NOS2;
Gene Name
NOS2
Gene Synonyms/Alias
NOS2A;
Created Date
01-FEB-1994
 Lipid Modification Sites 
 Position   Sequence Form   Peptide   References   Modification Type 
3
Canonical
*****MACPWKFLFK
[1][2]
S-Palmitoylation
Organism
Homo sapiens (Human)
NCBI Taxa ID
9606
Reference
[1] Navarro-Lérida I, Corvi MM, Barrientos AA, Gavilanes F, Berthiaume LG,Rodríguez-Crespo I. Palmitoylation of inducible nitric-oxide synthase at Cys-3 isrequired for proper intracellular traffic and nitric oxide synthesis. J BiolChem. 2004 Dec 31;279(53):55682-9. Epub 2004 Oct 13.[PMID:15485846]
[2] Navarro-Lérida I, Alvarez-Barrientos A, Rodríguez-Crespo I. N-terminalpalmitoylation within the appropriate amino acid environment conveys on NOS2 the ability to progress along the intracellular sorting pathways. J Cell Sci. 2006Apr 15;119(Pt 8):1558-69. Epub 2006 Mar 28. Erratum in: J Cell Sci. 2006 May1;119(Pt 9):1974.[PMID:16569659]
Functional Description
Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body. In macrophages, NO mediates tumoricidal and bactericidal actions. Also has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such COX2.
Sequence Annotation
Domain: 539 677 Flavodoxin-like.
Domain: 730 970 FAD-binding FR-type.
Nucleotide-binding: 623 654 FMN.
Nucleotide-binding: 767 778 FAD.
Nucleotide-binding: 903 913 FAD.
Nucleotide-binding: 978 996 NADP.
Nucleotide-binding: 1076 1091 NADP.
Region: 509 529 Calmodulin-binding.
Metal binding site: 110 110 Zinc.
Metal binding site: 115 115 Zinc.
Metal binding site: 200 200 Iron (heme axial ligand).
Modified residue: 234 234 Phosphoserine; by PKA.
Modified residue: 578 578 Phosphoserine; by PKA.
Modified residue: 892 892 Phosphoserine; by PKA.
Protein Length
1153 AA.
Protein Sequence
(Canonical)
MACPWKFLFK TKFHQYAMNG EKDINNNVEK APCATSSPVT QDDLQYHNLS KQQNESPQPL  60
VETGKKSPES LVKLDATPLS SPRHVRIKNW GSGMTFQDTL HHKAKGILTC RSKSCLGSIM  120
TPKSLTRGPR DKPTPPDELL PQAIEFVNQY YGSFKEAKIE EHLARVEAVT KEIETTGTYQ  180
LTGDELIFAT KQAWRNAPRC IGRIQWSNLQ VFDARSCSTA REMFEHICRH VRYSTNNGNI  240
RSAITVFPQR SDGKHDFRVW NAQLIRYAGY QMPDGSIRGD PANVEFTQLC IDLGWKPKYG  300
RFDVVPLVLQ ANGRDPELFE IPPDLVLEVA MEHPKYEWFR ELELKWYALP AVANMLLEVG  360
GLEFPGCPFN GWYMGTEIGV RDFCDVQRYN ILEEVGRRMG LETHKLASLW KDQAVVEINI  420
AVLHSFQKQN VTIMDHHSAA ESFMKYMQNE YRSRGGCPAD WIWLVPPMSG SITPVFHQEM  480
LNYVLSPFYY YQVEAWKTHV WQDEKRRPKR REIPLKVLVK AVLFACMLMR KTMASRVRVT  540
ILFATETGKS EALAWDLGAL FSCAFNPKVV CMDKYRLSCL EEERLLLVVT STFGNGDCPG  600
NGEKLKKSLF MLKELNNKFR YAVFGLGSSM YPRFCAFAHD IDQKLSHLGA SQLTPMGEGD  660
ELSGQEDAFR SWAVQTFKAA CETFDVRGKQ HIQIPKLYTS NVTWDPHHYR LVQDSQPLDL  720
SKALSSMHAK NVFTMRLKSR QNLQSPTSSR ATILVELSCE DGQGLNYLPG EHLGVCPGNQ  780
PALVQGILER VVDGPTPHQT VRLEALDESG SYWVSDKRLP PCSLSQALTY FLDITTPPTQ  840
LLLQKLAQVA TEEPERQRLE ALCQPSEYSK WKFTNSPTFL EVLEEFPSLR VSAGFLLSQL  900
PILKPRFYSI SSSRDHTPTE IHLTVAVVTY HTRDGQGPLH HGVCSTWLNS LKPQDPVPCF  960
VRNASGFHLP EDPSHPCILI GPGTGIAPFR SFWQQRLHDS QHKGVRGGRM TLVFGCRRPD  1020
EDHIYQEEML EMAQKGVLHA VHTAYSRLPG KPKVYVQDIL RQQLASEVLR VLHKEPGHLY  1080
VCGDVRMARD VAHTLKQLVA AKLKLNEEQV EDYFFQLKSQ KRYHEDIFGA VFPYEAKKDR  1140
VAVQPSSLEM SAL                                                     1153
FASTA
(Canonical)
>LipidDB-9606-00256|P35228
MACPWKFLFKTKFHQYAMNGEKDINNNVEKAPCATSSPVTQDDLQYHNLSKQQNESPQPL
VETGKKSPESLVKLDATPLSSPRHVRIKNWGSGMTFQDTLHHKAKGILTCRSKSCLGSIM
TPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQ
LTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNI
RSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYG
RFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVG
GLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINI
AVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEM
LNYVLSPFYYYQVEAWKTHVWQDEKRRPKRREIPLKVLVKAVLFACMLMRKTMASRVRVT
ILFATETGKSEALAWDLGALFSCAFNPKVVCMDKYRLSCLEEERLLLVVTSTFGNGDCPG
NGEKLKKSLFMLKELNNKFRYAVFGLGSSMYPRFCAFAHDIDQKLSHLGASQLTPMGEGD
ELSGQEDAFRSWAVQTFKAACETFDVRGKQHIQIPKLYTSNVTWDPHHYRLVQDSQPLDL
SKALSSMHAKNVFTMRLKSRQNLQSPTSSRATILVELSCEDGQGLNYLPGEHLGVCPGNQ
PALVQGILERVVDGPTPHQTVRLEALDESGSYWVSDKRLPPCSLSQALTYFLDITTPPTQ
LLLQKLAQVATEEPERQRLEALCQPSEYSKWKFTNSPTFLEVLEEFPSLRVSAGFLLSQL
PILKPRFYSISSSRDHTPTEIHLTVAVVTYHTRDGQGPLHHGVCSTWLNSLKPQDPVPCF
VRNASGFHLPEDPSHPCILIGPGTGIAPFRSFWQQRLHDSQHKGVRGGRMTLVFGCRRPD
EDHIYQEEMLEMAQKGVLHAVHTAYSRLPGKPKVYVQDILRQQLASEVLRVLHKEPGHLY
VCGDVRMARDVAHTLKQLVAAKLKLNEEQVEDYFFQLKSQKRYHEDIFGAVFPYEAKKDR
VAVQPSSLEMSAL
Gene Ontology
GO:0030863; C:cortical cytoskeleton; IEA:Ensembl
GO:0005737; C:cytoplasm; IDA:UniProtKB
GO:0005829; C:cytosol; IMP:BHF-UCL
GO:0005622; C:intracellular; IDA:BHF-UCL
GO:0005634; C:nucleus; ISS:BHF-UCL
GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl
GO:0005777; C:peroxisome; IDA:UniProtKB
GO:0034618; F:arginine binding; ISS:BHF-UCL
GO:0050660; F:flavin adenine dinucleotide binding; ISS:BHF-UCL
GO:0010181; F:FMN binding; ISS:BHF-UCL
GO:0020037; F:heme binding; ISS:BHF-UCL
GO:0005506; F:iron ion binding; IEA:InterPro
GO:0050661; F:NADP binding; TAS:BHF-UCL
GO:0003958; F:NADPH-hemoprotein reductase activity; IBA:RefGenome
GO:0004517; F:nitric-oxide synthase activity; IDA:UniProtKB
GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
GO:0005102; F:receptor binding; IPI:UniProtKB
GO:0034617; F:tetrahydrobiopterin binding; ISS:BHF-UCL
GO:0006527; P:arginine catabolic process; IDA:BHF-UCL
GO:0007596; P:blood coagulation; TAS:Reactome
GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl
GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
GO:0007623; P:circadian rhythm; IEA:Ensembl
GO:0042742; P:defense response to bacterium; ISS:UniProtKB
GO:0050829; P:defense response to Gram-negative bacterium; NAS:BHF-UCL
GO:0006954; P:inflammatory response; IBA:RefGenome
GO:0002227; P:innate immune response in mucosa; NAS:BHF-UCL
GO:0051701; P:interaction with host; TAS:Reactome
GO:0045776; P:negative regulation of blood pressure; IBA:RefGenome
GO:0010629; P:negative regulation of gene expression; IGI:UniProtKB
GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl
GO:0006809; P:nitric oxide biosynthetic process; IDA:UniProtKB
GO:0007263; P:nitric oxide mediated signal transduction; IBA:RefGenome
GO:0018119; P:peptidyl-cysteine S-nitrosylation; ISS:UniProtKB
GO:0090382; P:phagosome maturation; TAS:Reactome
GO:0031284; P:positive regulation of guanylate cyclase activity; IBA:RefGenome
GO:0051712; P:positive regulation of killing of cells of other organism; IMP:BHF-UCL
GO:0001912; P:positive regulation of leukocyte mediated cytotoxicity; TAS:BHF-UCL
GO:0045909; P:positive regulation of vasodilation; IBA:RefGenome
GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
GO:0043457; P:regulation of cellular respiration; TAS:BHF-UCL
GO:0050796; P:regulation of insulin secretion; IMP:BHF-UCL
GO:0009617; P:response to bacterium; NAS:UniProtKB
GO:0001666; P:response to hypoxia; IEA:Ensembl
GO:0006801; P:superoxide metabolic process; ISS:UniProtKB
Interpro
InterPro; IPR003097; FAD-binding_1
InterPro; IPR017927; Fd_Rdtase_FAD-bd
InterPro; IPR001094; Flavdoxin
InterPro; IPR008254; Flavodoxin/NO_synth
InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase
InterPro; IPR029039; Flavoprotein-like
InterPro; IPR023173; NADPH_Cyt_P450_Rdtase_dom3
InterPro; IPR012144; NOS_euk
InterPro; IPR004030; NOS_N
InterPro; IPR001433; OxRdtase_FAD/NAD-bd
InterPro; IPR017938; Riboflavin_synthase-like_b-brl
Pfam
Pfam; PF00667; FAD_binding_1;
Pfam; PF00258; Flavodoxin_1;
Pfam; PF00175; NAD_binding_1;
Pfam; PF02898; NO_synthase;
SMART
PROSITE
PROSITE; PS51384; FAD_FR;
PROSITE; PS50902; FLAVODOXIN_LIKE;
PROSITE; PS60001; NOS;
PRINTS
PRINTS; PR00369; FLAVODOXIN;
PRINTS; PR00371; FPNCR;